Elevated Serum Levels of CCL23 Are Associated with Poor Outcome after Resection of Biliary Tract Cancer

Figure 4

Postoperative CCL23 levels and patients’ outcome. (a) Postoperative CCL23 levels do not significantly differ from the respective preoperative serum levels. (b, c) Neither the median nor an optimal prognostic cut-off value for postoperative CCL23 serum levels is able to identify BTC patients with a favorable or unfavorable postoperative outcome. (d) Individual changes of CCL23 levels before and after tumor resection (positive or negative delta) are unable to predict outcome of BTC patients.

(a)

(b)

(c)

(d)